Rights and permissions
About this article
Cite this article
Infliximab's QOL effect clinically meaningful in rheumatic disorders. Pharmacoecon. Outcomes News 485, 13 (2005). https://doi.org/10.2165/00151234-200504850-00031
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504850-00031